Zdrowie i gospodarka · 04/08/2004

FDA Clears Esmolol Hydrochloride Injection and Ketorolac Tromethamine Injection for Sale

The US Food and Drug Administration (FDA) has ruled that the two medications, Esmolol Hydrochloride Injection and Ketorolac Tromethamine Injection, were not withdrawn from the market due to safety or effectiveness concerns, allowing the FDA to continue approving Abbreviated New Drug Applications (ANDAs) for these products.